250 related articles for article (PubMed ID: 30552317)
1. Exploratory genome-wide association analysis of response to ketamine and a polygenic analysis of response to scopolamine in depression.
Guo W; Machado-Vieira R; Mathew S; Murrough JW; Charney DS; Grunebaum M; Oquendo MA; Kadriu B; Akula N; Henter I; Yuan P; Merikangas K; Drevets W; Furey M; Mann JJ; McMahon FJ; Zarate CA; Shugart YY
Transl Psychiatry; 2018 Dec; 8(1):280. PubMed ID: 30552317
[TBL] [Abstract][Full Text] [Related]
2. Neurophysiological Changes Associated with Antidepressant Response to Ketamine Not Observed in a Negative Trial of Scopolamine in Major Depressive Disorder.
Park L; Furey M; Nugent AC; Farmer C; Ellis J; Szczepanik J; Lener MS; Zarate CA
Int J Neuropsychopharmacol; 2019 Jan; 22(1):10-18. PubMed ID: 30184133
[TBL] [Abstract][Full Text] [Related]
3. Symptomatology and predictors of antidepressant efficacy in extended responders to a single ketamine infusion.
Pennybaker SJ; Niciu MJ; Luckenbaugh DA; Zarate CA
J Affect Disord; 2017 Jan; 208():560-566. PubMed ID: 27839782
[TBL] [Abstract][Full Text] [Related]
4. Parsing the heterogeneity of depression: An exploratory factor analysis across commonly used depression rating scales.
Ballard ED; Yarrington JS; Farmer CA; Lener MS; Kadriu B; Lally N; Williams D; Machado-Vieira R; Niciu MJ; Park L; Zarate CA
J Affect Disord; 2018 Apr; 231():51-57. PubMed ID: 29448238
[TBL] [Abstract][Full Text] [Related]
5. Features of dissociation differentially predict antidepressant response to ketamine in treatment-resistant depression.
Niciu MJ; Shovestul BJ; Jaso BA; Farmer C; Luckenbaugh DA; Brutsche NE; Park LT; Ballard ED; Zarate CA
J Affect Disord; 2018 May; 232():310-315. PubMed ID: 29501990
[TBL] [Abstract][Full Text] [Related]
6. Antidepressant treatment history as a predictor of response to scopolamine: clinical implications.
Ellis JS; Zarate CA; Luckenbaugh DA; Furey ML
J Affect Disord; 2014 Jun; 162():39-42. PubMed ID: 24767003
[TBL] [Abstract][Full Text] [Related]
7. Family history of alcohol dependence and antidepressant response to an N-methyl-D-aspartate antagonist in bipolar depression.
Luckenbaugh DA; Ibrahim L; Brutsche N; Franco-Chaves J; Mathews D; Marquardt CA; Cassarly C; Zarate CA
Bipolar Disord; 2012 Dec; 14(8):880-7. PubMed ID: 22978511
[TBL] [Abstract][Full Text] [Related]
8. Case-control association study of 14 variants of CREB1, CREBBP and CREM on diagnosis and treatment outcome in major depressive disorder and bipolar disorder.
Crisafulli C; Shim DS; Andrisano C; Pae CU; Chiesa A; Han C; Patkar AA; Lee SJ; Serretti A; De Ronchi D
Psychiatry Res; 2012 Jun; 198(1):39-46. PubMed ID: 22386572
[TBL] [Abstract][Full Text] [Related]
9. Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial.
Furey ML; Drevets WC
Arch Gen Psychiatry; 2006 Oct; 63(10):1121-9. PubMed ID: 17015814
[TBL] [Abstract][Full Text] [Related]
10. Assessing measures of suicidal ideation in clinical trials with a rapid-acting antidepressant.
Ballard ED; Luckenbaugh DA; Richards EM; Walls TL; Brutsché NE; Ameli R; Niciu MJ; Vande Voort JL; Zarate CA
J Psychiatr Res; 2015 Sep; 68():68-73. PubMed ID: 26228403
[TBL] [Abstract][Full Text] [Related]
11. Scopolamine produces larger antidepressant and antianxiety effects in women than in men.
Furey ML; Khanna A; Hoffman EM; Drevets WC
Neuropsychopharmacology; 2010 Nov; 35(12):2479-88. PubMed ID: 20736989
[TBL] [Abstract][Full Text] [Related]
12. Neural correlates of rapid antidepressant response to ketamine in bipolar disorder.
Nugent AC; Diazgranados N; Carlson PJ; Ibrahim L; Luckenbaugh DA; Brutsche N; Herscovitch P; Drevets WC; Zarate CA
Bipolar Disord; 2014 Mar; 16(2):119-28. PubMed ID: 24103187
[TBL] [Abstract][Full Text] [Related]
13. Do the dissociative side effects of ketamine mediate its antidepressant effects?
Luckenbaugh DA; Niciu MJ; Ionescu DF; Nolan NM; Richards EM; Brutsche NE; Guevara S; Zarate CA
J Affect Disord; 2014 Apr; 159():56-61. PubMed ID: 24679390
[TBL] [Abstract][Full Text] [Related]
14. Effect of baseline anxious depression on initial and sustained antidepressant response to ketamine.
Ionescu DF; Luckenbaugh DA; Niciu MJ; Richards EM; Slonena EE; Vande Voort JL; Brutsche NE; Zarate CA
J Clin Psychiatry; 2014 Sep; 75(9):e932-8. PubMed ID: 25295436
[TBL] [Abstract][Full Text] [Related]
15. Genetic relationships between suicide attempts, suicidal ideation and major psychiatric disorders: a genome-wide association and polygenic scoring study.
Mullins N; Perroud N; Uher R; Butler AW; Cohen-Woods S; Rivera M; Malki K; Euesden J; Power RA; Tansey KE; Jones L; Jones I; Craddock N; Owen MJ; Korszun A; Gill M; Mors O; Preisig M; Maier W; Rietschel M; Rice JP; Müller-Myhsok B; Binder EB; Lucae S; Ising M; Craig IW; Farmer AE; McGuffin P; Breen G; Lewis CM
Am J Med Genet B Neuropsychiatr Genet; 2014 Jul; 165B(5):428-37. PubMed ID: 24964207
[TBL] [Abstract][Full Text] [Related]
16. A randomized clinical trial of adjunctive ketamine anesthesia in electro-convulsive therapy for depression.
Zhang M; Rosenheck R; Lin X; Li Q; Zhou Y; Xiao Y; Huang X; Fan N; He H
J Affect Disord; 2018 Feb; 227():372-378. PubMed ID: 29149755
[TBL] [Abstract][Full Text] [Related]
17. The role of adipokines in the rapid antidepressant effects of ketamine.
Machado-Vieira R; Gold PW; Luckenbaugh DA; Ballard ED; Richards EM; Henter ID; De Sousa RT; Niciu MJ; Yuan P; Zarate CA
Mol Psychiatry; 2017 Jan; 22(1):127-133. PubMed ID: 27046644
[TBL] [Abstract][Full Text] [Related]
18. Change in cytokine levels is not associated with rapid antidepressant response to ketamine in treatment-resistant depression.
Park M; Newman LE; Gold PW; Luckenbaugh DA; Yuan P; Machado-Vieira R; Zarate CA
J Psychiatr Res; 2017 Jan; 84():113-118. PubMed ID: 27718369
[TBL] [Abstract][Full Text] [Related]
19. Baseline delta sleep ratio predicts acute ketamine mood response in major depressive disorder.
Duncan WC; Selter J; Brutsche N; Sarasso S; Zarate CA
J Affect Disord; 2013 Feb; 145(1):115-9. PubMed ID: 22871531
[TBL] [Abstract][Full Text] [Related]
20. Neurocognitive effects of ketamine and association with antidepressant response in individuals with treatment-resistant depression: a randomized controlled trial.
Murrough JW; Burdick KE; Levitch CF; Perez AM; Brallier JW; Chang LC; Foulkes A; Charney DS; Mathew SJ; Iosifescu DV
Neuropsychopharmacology; 2015 Mar; 40(5):1084-90. PubMed ID: 25374095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
